XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ / shares in Units, ₪ in Thousands, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 02, 2023
ILS (₪)
May 16, 2023
Oct. 06, 2022
USD ($)
Mar. 31, 2021
USD ($)
Feb. 04, 2020
USD ($)
Apr. 28, 2019
USD ($)
Jan. 04, 2018
USD ($)
$ / shares
shares
Jan. 04, 2018
ILS (₪)
shares
Jun. 30, 2012
Jun. 30, 2023
USD ($)
 [1]
Mar. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                          
Gross proceeds from cash fee percentage   7.00%                      
Gross proceeds from management fee percentage   1.00%                      
Stock issued during period, value, new issues                   $ 6,558    
Net loss on trading of common stock         $ 151                
Joseph Mona [Member]                          
Loss Contingencies [Line Items]                          
Purchase price of plaintiffs       $ 485                  
Device [Member]                          
Loss Contingencies [Line Items]                          
Royalties percentage     3.00%                    
Integrated Product [Member]                          
Loss Contingencies [Line Items]                          
Royalties percentage     1.50%                    
Securities Purchase Agreement [Member]                          
Loss Contingencies [Line Items]                          
Purchase price of plaintiffs                       $ 6,750  
Israeli Innovation Authority [Member]                          
Loss Contingencies [Line Items]                          
Grants receivable | ₪ ₪ 1,620                        
Currency exchange rate, description exchange rate on such date of NIS 1.00 = $0.26675, would be approximately $433                        
Israeli Innovation Authority [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Royalties payable as percentage of future sales                       3.00%  
Israeli Innovation Authority [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Royalties payable as percentage of future sales                       5.00%  
Israeli Innovation Authority [Member] | CardioSert Ltd. [Member]                          
Loss Contingencies [Line Items]                          
Repayment of government grants             $ 530            
Israeli Innovation Authority [Member] | Nitiloop [Member]                          
Loss Contingencies [Line Items]                          
Repayment of government grants     $ 925                    
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                          
Loss Contingencies [Line Items]                          
Royalties payable as percentage of future sales                 1.50%        
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                          
Loss Contingencies [Line Items]                          
Royalties payable as percentage of future sales                 3.00%        
CardioSert Ltd. [Member] | Technology [Member]                          
Loss Contingencies [Line Items]                          
Currency exchange rate, description             exchange rate of NIS 3.7 to the dollar exchange rate of NIS 3.7 to the dollar          
Payment to acquire intangible assets             $ 300            
Number of common shares issued for acquisition | shares             6,738 6,738          
Number of common shares issued for acquisition, value             $ 74            
Buy back amount per patent | $ / shares             $ 1.00            
Consulting fee description             Additionally, the agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS40,000 (or approximately US$11, based on an exchange rate of NIS 3.7 to the dollar) covering up to 60 consulting hours per month, relating to the development of the Technology. Additionally, the agreement may be terminated by either party upon breach of the other (subject to cure). Until May 2023, Microbot Israel paid CardioSert a monthly consultation fee of NIS40,000 (or approximately US$11, based on an exchange rate of NIS 3.7 to the dollar) covering up to 60 consulting hours per month, relating to the development of the Technology.          
Monthly consultation fee | ₪               ₪ 40,000          
Monthly consultation fee in USD | $ / shares             $ 11            
CardioSert Ltd. [Member] | Minimum [Member] | Technology [Member]                          
Loss Contingencies [Line Items]                          
Investments             $ 2,000            
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                          
Loss Contingencies [Line Items]                          
Offering costs                         $ 10,000
Stock issued during period, value, new issues     $ 8,000                    
Alliance Investment Management, Ltd. [Member]                          
Loss Contingencies [Line Items]                          
Litigation settlement           $ 468              
2013 To June 30, 2023 [Member] | Israeli Innovation Authority [Member]                          
Loss Contingencies [Line Items]                          
Total grants obtained                       $ 1,500  
[1] Net of issuance costs in the amount of $1,075, of which $160 had not been paid as of June 30, 2023. See also Note 5.